Source:http://linkedlifedata.com/resource/pubmed/id/12826155
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-6-26
|
pubmed:abstractText |
It was recently shown that IL-2 gene single nucleotide polymorphism (SNP) at position -330 (G-->T) is related to in vitro cytokine production levels, with the T/T and T/G genotypes being associated with low production and the G/G genotype associated with high production. The objective of this study was to investigate a possible influence of this polymorphism on renal and cardiac allograft outcomes. IL-2 SNP G-T (-330) was determined by PCR-RFLP in 67 recipients of heart allografts and in 63 recipients of renal grafts from HLA-haplo-identical, related donors. A higher frequency of the T/T genotype was observed in renal transplant patients who experienced at least one acute rejection episode during the first 3 months after transplantation than in those without rejection during this period (80% vs 49%, respectively, P <.05). Accordingly, the same genotype tended to be more frequent in renal recipients with a 6-month serum creatinine level above 1.5 mg/dL (median value for the whole group of kidney recipients) than in patients with lower creatinine levels (79% vs 45%, P <.08). Regarding cardiac transplant recipients, no associations were observed concerning acute rejection or graft survival. The finding of the association of T/T but not T/G genotype with acute kidney rejection was unexpected considering that both genotypes were shown to be associated with equal (low) IL-2 in vitro production. Further studies are necessary not only to dissect the nature of IL-2 T/T genotype association with kidney rejection, but also to explain why this genotype does not apparently influence cardiac allograft outcome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0041-1345
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1344-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12826155-Acute Disease,
pubmed-meshheading:12826155-Creatinine,
pubmed-meshheading:12826155-Genotype,
pubmed-meshheading:12826155-Graft Survival,
pubmed-meshheading:12826155-Heart Transplantation,
pubmed-meshheading:12826155-Histocompatibility Testing,
pubmed-meshheading:12826155-Humans,
pubmed-meshheading:12826155-Interleukin-2,
pubmed-meshheading:12826155-Kidney Transplantation,
pubmed-meshheading:12826155-Phenotype,
pubmed-meshheading:12826155-Polymorphism, Genetic,
pubmed-meshheading:12826155-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:12826155-Polymorphism, Single Nucleotide,
pubmed-meshheading:12826155-Time Factors,
pubmed-meshheading:12826155-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Interleukin-2 gene polymorphism is associated with renal but not cardiac transplant outcome.
|
pubmed:affiliation |
Division of Immunogenetics, Department of Pediatrics, São Paulo, Brazil.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|